Intestinal Microbiota and Metabolic Diseases: Pharmacological Implications

Trends in Pharmacological Sciences

Volumn 37, Issue 3, 2016, Pages 169-171

  Shen, Liang ^a   Ji, Hong Fang ^a  

^a SHANDONG UNIVERSITY OF TECHNOLOGY   (China)

Author keywords

intestinal microbiota; metabolic diseases; pharmacology; polyphenols

Indexed keywords

POLYPHENOL; QUERCETIN; SILYMARIN;

BACTERIAL GROWTH; BACTERIAL STRAIN; BACTEROIDES; BACTEROIDES (CLASS); BACTEROIDES GALACTURONICUS; BACTEROIDETES; BIFIDOBACTERIUM; BIFIDOBACTERIUM CATENULATUM; BODY MASS; CLOSTRIDIUM PERFRINGENS; DIET; DISEASE ASSOCIATION; DISEASE COURSE; DRUG ACTIVITY; DRUG BIOAVAILABILITY; ENTEROCOCCUS; ENTEROCOCCUS CACCAE; ESCHERICHIA COLI; HUMAN; INTESTINE FLORA; LACTOBACILLUS; METABOLIC DISORDER; MICROBIAL COMMUNITY; NON INSULIN DEPENDENT DIABETES MELLITUS; NONALCOHOLIC FATTY LIVER; NONHUMAN; OXIDATIVE STRESS; PEPTOCLOSTRIDIUM DIFFICILE; PRIORITY JOURNAL; REVIEW; RUMINOCOCCUS; RUMINOCOCCUS GAUVREAUII; INTESTINE; METABOLIC DISEASES; MICROBIOLOGY; MICROFLORA;

HUMANS; INTESTINES; METABOLIC DISEASES; MICROBIOTA; POLYPHENOLS;

EID: 84958771911     PISSN: 01656147     EISSN: 18733735     Source Type: Journal    
DOI: 10.1016/j.tips.2015.11.010     Document Type: Short Survey

References (12)

1. J.K. Nicholson, and et al. Host-gut microbiota metabolic interactions Science 336 2012 1262 1267
2. M. Mouzaki, and et al. Intestinal microbiota in patients with nonalcoholic fatty liver disease Hepatology 58 2013 120 127
3. L. Zhu, and et al. Characterization of gut microbiomes in nonalcoholic steatohepatitis (NASH) patients: a connection between endogenous alcohol and NASH Hepatology 57 2013 601 609
4. F.H. Karlsson, and et al. Gut metagenome in European women with normal, impaired and diabetic glucose control Nature 498 2013 99 103
5. E. Marcolin, and et al. Quercetin treatment ameliorates inflammation and fibrosis in mice with nonalcoholic steatohepatitis J. Nutr. 142 2012 1821 1828
6. E. Nicolle, and et al. Flavonoids as promising lead compounds in type 2 diabetes mellitus: molecules of interest and structure-activity relationship Curr. Med. Chem. 18 2011 2661 2672
7. J.W. Wu, and et al. Analysis of silibinin in rat plasma and bile for hepatobiliary excretion and oral bioavailability application J. Pharm. Biomed. Anal. 45 2007 635 641
8. D.J. Boocock, and et al. Phase I dose escalation pharmacokinetic study in healthy volunteers of resveratrol, a potential cancer chemopreventive agent Cancer Epidemiol. Biomarkers Prev. 16 2007 1246 1252
9. A. Duda-Chodak The inhibitory effect of polyphenols on human gut microbiota J. Physiol. Pharmacol. 63 2012 497 503
10. H.C. Lee, and et al. Effect of tea phenolics and their aromatic fecal bacterial metabolites on intestinal microbiota Res. Microbiol. 157 2006 876 884
11. T. Okubo, and et al. In vivo effects of tea polyphenol intake on human intestinal microflora and metabolism Biosci. Biotechnol. Biochem. 56 1992 588 591
12. M.I. Queipo-Ortuno, and et al. Influence of red wine polyphenols and ethanol on the gut microbiota ecology and biochemical biomarkers Am. J. Clin. Nutr. 95 2012 1323 1334